Revenues Working Against Pacira BioSciences, Inc.’s (NASDAQ:PCRX) Share Price Following 28% Dive
Pacira BioSciences, Inc. (NASDAQ:PCRX) shareholders won’t be pleased to see that the share price has had a very rough month, dropping 28% and undoing the prior period’s positive performance. Instead of being rewarded, shareholders who have already held through the last twelve months are now sitting on a 14% share price drop.
Even after such a large drop in price, Pacira BioSciences may still be sending very bullish signals at the moment with its price-to-sales (or “P/S”) ratio of 1.1x, since almost half of all companies in the Pharmaceuticals industry in the United States have P/S ratios greater than 4.7x and even P/S higher than 25x are not unusual. However, the P/S might be quite low for a reason and it requires further…
